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ABSTRACT
The biological aldehydes, malondialdehyde and
base propenal, react with DNA to form a prevalent
guanine adduct, M1dG. The exocyclic ring of
M1dG opens to the acyclic N
2-OPdG structure
when paired with C but remains closed in single-
stranded DNA or when mispaired with T. M1dG is a
target of nucleotide excision repair (NER); however,
NER is absent in mitochondria. An in vitro transcrip-
tion system with purified human mitochondrial
RNA polymerase (POLRMT) and transcription
factors, mtTFA and mtTFB2, was used to determine
the effect of M1dG on POLRMT elongation. DNA
templates contained a single adduct opposite
either C or T downstream of either the light-strand
(LSP) or heavy-strand (HSP1) promoter for POLRMT.
M1dG in the transcribed strand arrested 60–90%
POLRMT elongation complexes with greater
arrest by the adduct when opposite T. POLRMT
was more sensitive to N
2-OPdG and M1dG after
initiation at LSP, which suggests promoter-specific
differences in the function of POLRMT complexes.
A closed-ring analog of M1dG, PdG, blocked  95%
of transcripts originating from either promoter
regardless of base pairing, and the transcripts
remained associated with POLRMT complexes
after stalling at the adduct. This work suggests
that persistent M1dG adducts in mitochondrial
DNA hinder the transcription of mitochondrial
genes.
INTRODUCTION
The mitochondria of eukaryotic cells each harbor multiple
copies of a 16569bp circular chromosome that must be
maintained for efﬁcient cellular energy production (1,2).
Electrons that escape from the transport chain in the inner
membrane react with molecular oxygen and water to
produce reactive oxygen species (ROS) in the matrix
where mitochondrial DNA (mtDNA) resides (3). The
ROS may damage mtDNA directly by oxidation of
bases or the sugar backbone. Additionally, ROS oxidation
of DNA and inner membrane lipids generates biological
aldehydes, such as base propenals, malondialdehyde
(MDA) and 4-hydroxynonenal, which react with nucleic
acid bases (4). The base propenals generated from DNA
sugar backbone oxidation appear to be the major
endogenous source of the 3-(20-deoxy-b-D-erythro-
pentofuranosyl)pyrimido[1,2-a]purin-10(3H)-one adduct
of guanine known as M1dG (Figure 1) (5–8). M1dG has
been reported to occur in human tissues at levels compar-
able to the most abundant form of base oxidation,
8-oxodeoxyguanine, and to be twice as prevalent in
mtDNA than in nuclear chromosomes (4,8–12). In eu-
karyotic cell nuclei, excision repair pathways remove
modiﬁed bases and maintain genetic integrity. Base
excision repair (BER), which removes oxidized bases
such as 8-oxodeoxyguanine and thymine glycol, also func-
tions in mitochondria (13–15). Conversely, nucleotide
excision repair (NER), the mechanism implicated in pro-
cessing of M1dG, is absent in the organelle (16–18). The
lack of NER and the presence of ROS in the mitochon-
drial matrix may contribute synergistically to the persist-
ence of M1dG in mtDNA.
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base damage particularly interesting with respect to its
potential detriment to DNA replication and gene expres-
sion. As seen in Figure 1, the external ring of M1dG is
closed in single-stranded DNA or when mispaired with
thymine, but opens to an acyclic N
2-(3-oxo-1-propenyl)-
dG derivative (N
2-OPdG), when correctly paired in DNA
with cytosine (19,20). Therefore, a single aldehyde modi-
ﬁcation of DNA to form M1dG may result in two struc-
turally distinct adducts that must be negotiated by DNA
and RNA polymerases and recognized by DNA repair
pathways. A chemically stable M1dG analog, 1,N
2-
propano-20-deoxyguanosine, called PdG, has been used
to elucidate differences in M1dG and N
2-OPdG effects
on prokaryotic and eukaryotic polymerases.
In bacteria and mammalian cells, M1dG causes a high
rate of frameshifts and base substitutions during replica-
tion (21–24). M1dG and PdG disrupt nucleotide insertion
and translocation by the Klenow fragment of bacterial
DNA polymerase I (25), the human BER polymerase,
DNA pol b (26,27), and the human translesion DNA
polymerase, pol Z (28,29). Recent in vitro transcription
studies revealed a structure-dependent M1dG arrest of
elongation by the T7 bacteriophage RNA polymerase
(T7RNAP) and by mammalian RNA polymerase II
(RNAP II) that suggests M1dG may also disrupt gene
expression (30). Both polymerases exhibited a greater
transcriptional arrest at M1dG opposite T; however,
RNAP II elongation complexes were more sensitive than
T7RNAP to both biological forms of the adduct. PdG, the
analog of the closed-ring M1dG, completely blocked
RNAP II translocation regardless of the opposing base
(30). Human mitochondrial RNA polymerase
(POLRMT) is a single subunit enzyme homologous to
T7RNAP; therefore, M1dG and its acyclic N
2-OPdG con-
formation may substantially hinder POLRMT transcript
elongation. In addition, POLRMT, like RNAP II,
requires the assistance of other proteins for promoter ini-
tiation, a property that could inﬂuence POLRMT
behavior upon encountering DNA damage (1,31–34). As
POLRMT elongation remains largely uncharacterized,
studies of POLRMT interaction with M1dG provide not
only information about the biological impact of mtDNA
damage on mitochondrial gene expression but also under-
standing of basic POLRMT function.
POLRMT transcription initiates at different promoter
sequences on the heavy (H) strand and the light (L) strand
of the mitochondrial chromosome and produces
polycistronic RNAs (1,31,35–37). The H strand contains
genes for 12 of the 13 mtDNA-encoded proteins and the
mitochondrial ribosomal RNA (rRNA) and transfer
RNA (tRNA) required for translation of the proteins.
The heavy strand promoter HSP1 is thought to primarily
direct the synthesis of a transcript including 12S and 16S
rRNA that terminates in the tRNA
Leu gene (38), while a
second promoter, HSP2, has been proposed to be the site
for messenger RNA and tRNA production from the H
strand (39). The L strand promoter, LSP, not only
permits POLRMT transcription, but also controls
POLRMT synthesis of an RNA primer for mtDNA rep-
lication at the H strand origin (40–42). The nuclear-
encoded proteins, mtTFA, mtTFB1 and mtTFB2,
support promoter-directed transcription of mtDNA by
POLRMT (1,2,31,43,44). The combination of mtTFA
and mtTFB2 maximally stimulates POLRMT activity at
LSP and HSP1 in vitro, while the primary role of mtTFB1
appears to be as an rRNA methyltransferase that helps to
link mtDNA transcription and translation (1,31,33,34,
45–47). Given the different roles of LSP and HSP1 in
directing activities on the mitochondrial chromosome,
DNA damage that interferes with POLRMT transcript
elongation could hinder both mtDNA gene expression
and replication.
To investigate the consequences of M1dG on transcript
elongation by POLRMT and gain insight into POLRMT
function, we employed an in vitro transcription system
containing puriﬁed human POLRMT, transcription
factors, mtTFA and mtTFB2, and DNA templates con-
taining a site-speciﬁc M1dG or PdG in either the
transcribed (Xts) or non-transcribed (Xnts) strand down-
stream of LSP or HSP1 (Figure 2). M1dG was placed
opposite either C or T to elucidate the structural effects
of N
2-OPdG and M1dG, respectively, on POLRMT. The
DNA sequence context of the adduct within
the POLRMT templates was identical to that used in the
previous studies of RNAP II and T7RNAP, allowing for a
comparison of the elongation behavior of these polymer-
ases. In light of the results showing substantial M1dG
effects on T7RNAP and RNAP II transcription, we
hypothesized that M1dG would impede POLRMT elong-
ation in a structure-dependent manner suggesting that
persistent M1dG adducts may disrupt the expression of
Figure 1. Formation of M1dG by malondialdehyde (MDA) and base
propenal. The exocyclic adduct, M1dG, can react with the amino group
of a paired cytosine and form acyclic N
2-OPdG. PdG is a stable analog
of the closed-ring M1dG.
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tinctly different promoters on the mitochondrial chromo-
some, we believed that our system also would provide
insight into potential promoter-dependent properties of
POLRMT elongation, such as the response of POLRMT
to mtDNA sequences that govern transcript length.
MATERIALS AND METHODS
Reagents
T4 polynucleotide kinase, T4 DNA polymerase and
M13K07 helper phage were purchased from New
England Biolabs (Beverly, MA, USA), and T4 DNA
ligase was from Invitrogen (Carlsbad, CA, USA). The F0
Escherichia coli strain MV1184 was developed by
J. Messing (Rutgers University, Piscataway, NJ, USA).
Non-radioactive ribonucleoside and deoxyribonucleoside
triphosphates were purchased from GE Healthcare Bio-
sciences Corp (Piscataway, NJ, USA). Radionuclides,
[a-
32P] UTP, [a-
32P] CTP and [g-
32P] ATP, were
obtained from Perkin Elmer (Boston, MA, USA).
Unmodiﬁed oligonucleotides were synthesized by
Euroﬁns MWG Operon (Huntsville, AL, USA).
Streptavidin-linked paramagnetic particles were from
Promega (Madison, WI, USA).
Preparation of Oligonucleotides
Oligonucleotides of the 18-base sequence 50-ATC GGC
GCC GXC GGT GTG-30 containing either a single
M1dG or PdG at the position X were synthesized as pre-
viously described (48), and their purity and presence of the
adduct was veriﬁed by mass spectrometry. Samples of the
oligonucleotides were
32P labeled and resolved by
denaturing polyacrylamide gel electrophoresis (PAGE)
to check for degradation that could affect construction
of the plasmid templates below. The undamaged 18-mer
(X=dG) and the oligonucleotides for both strands of
LSP and HSP1 were prepared by Euroﬁns MWG
Operon (Huntsville, AL, USA). The LSP and HSP1 se-
quences were as follows: LSP nontranscribed strand,
50-AAT TCA TGT GTT AGT TGG GGG GTG ACT
GTT AAA AGT GCA TAC CGC CAA AAG ATA
AAA TTT GAA ATC T-30; LSP transcribed strand,
30-GTA CAC AAT CAA CCC CCC ACT GAC AAT
TTT CAC GTA TGG CGG TTT TCT ATT TTA AAC
TTT AGA GAT C-50; HSP1 nontranscribed strand,
50-AAT TCC GCT GCT AAC CCC ATA CCC CGA
ACC AAC CAA ACC CCA AAG ACA CCC CCC
T-30; and HSP1 transcribed strand, 30-GGC GAC GAT
TGG GGT ATG GGG CTT GGT TGG TTT GGG GTT
TCT GTG GGG GGA GAT C-50. These sequences were
designed according to studies of human mtDNA pro-
moters by the Clayton group with modiﬁcations to facili-
tate transcription template construction (37)
Construction of transcription templates
The plasmid transcription templates for POLRMT were
constructed from plasmids used in previously published
studies of RNAP II and T7RNAP transcriptional arrest
(30). The identical sequence context for the adduct
position (Figure 2, X) was maintained allowing functional
comparisons of the three polymerases. In brief, a
double-stranded oligonucleotide containing either the
mitochondrial LSP or HSP1 sequence modiﬁed to create
a ‘labeling cassette’ downstream of the promoter was
ligated, at a 20:1 molar ratio of oligonucleotide to
vector, into the EcoRI–XbaI cloning site replacing the
T7RNAP promoter (30) (Figure 2). The constructs were
transformed into the F0 E. coli strain MV1184 for replica-
tion of the plus strand by the M13K07 phage. Plasmids
containing dG, M1dG or PdG in either the transcribed or
nontranscribed strand were prepared by T4 DNA poly-
merase second-strand synthesis on a single-stranded
plasmid using the appropriate 18-mer as a primer (49).
For each synthesis, a control reaction without the
18-mer was performed to insure that no intact plasmid
was generated from aberrant priming by the single-
stranded DNA. Products were resolved by electrophoresis
in TAE (40mM Tris–acetate, 2mM disodium EDTA,
Figure 2. DNA transcription templates for POLRMT. The linear Xts
and Xnts DNA templates contain dG, M1dG or PdG (X) either in the
transcribed or nontranscribed strands, respectively, downstream of pro-
moters for POLRMT transcription (LSP and HSP1) and paired with
either C or T. Numbers in parentheses indicate positions in the DNA
plasmid construct. Transcript lengths in nucleotides expected from
run-off (RO) or from adduct-arrest (X) are depicted below each
template. Transcription started at each promoter (+1) and proceeded
in the direction of the bent arrows. Transcripts were labeled by
[a-
32P]-ribonucleotide incorporation within a ‘labeling cassette’
between the bent arrows on each template diagram. Omission of the
NTP needed at +19 for LSP templates and +14 for HSP1 templates
stalled POLRMT complexes and facilitated the analysis of transcripts
from a single-round of POLRMT transcription on each DNA
molecule.
7548 Nucleic Acids Research, 2010,Vol.38, No. 21pH 8.5) on 1% agarose containing 0.3mg/ml ethidium
bromide. Plasmids were excised, electroeluted from the
gel using an Amicon Centrilutor (Millipore, Billerica,
MA, USA), and concentrated by centrifugation. The con-
structs were digested with HindIII, then gel puriﬁed and
isolated as described earlier.
The 118-bp POLRMT transcription templates were
constructed by equimolar annealing of 79-, 18- and 21-
base transcribed strand oligonucleotides to a 118-base
nontranscribed strand sequence followed by ligation
with T4 DNA ligase for 12–16h at 16 C. The 18-mer
was the same PdG-adducted sequence utilized above,
and the 21-mer comprising the 50 end of the transcribed
strand contained a 50 biotin. The ligation reactions were
extracted with 25:24:1 phenol/chloroform/isoamyl alcohol
and ﬁltered through G-25 then G-100 Sephadex to remove
contaminates and unligated transcribed strand 18-mer and
biotinylated 21-mer. The 118-bp templates were resolved
on 3.5% agarose to ensure purity. The concentration of
each template was determined by ultraviolet spectropho-
tometry with a Shimadzu ND-1000 Nanodrop instrument
(Columbia, MD, USA).
POLRMT in vitro transcription
Recombinant human POLRMT, mtTFA and mtTFB2
were puriﬁed from E. coli by previously published proto-
cols with modiﬁcations submitted separately for publica-
tion (43,50,51). Proteins of comparable quality from these
preparations can be obtained from Enzymax, LLC
(Lexington, KY, USA), which has not provided funding
for or inﬂuenced the research reported herein. For
promoter binding of transcription factors, 100nM
mtTFA and 24nM mtTFB2 were incubated at 32 C for
5min with 4nM LSP or HSP templates in POLRMT tran-
scription buffer (10mM HEPES, pH 7.9, 10mM MgCl2,
20mM NaCl, 0.1mg/ml bovine serum albumin, 1mM
dithiothreitol). Reactions for LSP template binding con-
tained 100mM ATP, 20mM GTP, 10mM UTP and 0.1mM
[a-
32P] UTP (3000Ci/mmol) and those for HSP template
binding contained 100mM ATP, 20mM GTP, 10mM CTP
and 0.1mM[ a-
32P] CTP (3000Ci/mmol). Addition of
20nM POLRMT initiated transcription at each
promoter and continued incubation at 32 C allowed
POLRMT extension of transcripts to the end of the
‘labeling cassette’ in each template (Figure 2). By
excluding the next ribonucleotide required for transcript
extension (CTP for the LSP templates and UTP for the
HSP1 templates), POLRMT complexes were stalled until
ribonucleoside triphosphate (NTP) addition. After 5min
for LSP template reactions and 10min for HSP template
reactions, heparin was added at 50ng/ml to inactivate un-
initiated POLRMT, then elongation by the stalled
POLRMT complexes was induced by increasing all four
NTP concentrations to 400mM. The incubation times
chosen for POLRMT initiation provided the maximal
amount of cassette-arrested transcripts that remained
competent for elongation following heparin and NTP
addition. Control reactions conﬁrming heparin inhibition
of POLRMT re-initiation and an absence of additional
32P incorporation during elongation are shown in
Supplementary Data (Figure S1). After elongation times
up to 30min at 32 C, reactions were stopped with 0.3%
SDS/22.5mM EDTA, proteins digested with 0.4mg/ml
proteinase K, and nucleic acids precipitated with ethanol
by centrifugation. Samples were dried under vacuum, re-
suspended in 80% formamide dye, and resolved by
denaturing 5% polyacrylamide gel electrophoresis in
TBE (89mM Tris-borate, 1mM EDTA, pH 8.0). The
gels were dried, and then transcripts were detected by
phosphorimaging analysis using a Storm 840 system
with Image Quant software (GE Healthcare Bio-sciences
Corp, Piscataway, NJ, USA).
POLRMT transcription complex stability
The stability of PdG-arrested POLRMT complexes was
assessed by isolation of transcripts produced from a
biotinylated 118-bp template linked to streptavidin-
conjugated paramagnetic particles (SA-PMPs). Brieﬂy,
SA-PMPs were washed in cold POLRMT oligonucleotide
transcription buffer (10mM HEPES, pH 7.5, 10mM
MgCl2, 100mM NaCl, 0.1mg/ml bovine serum albumin,
1mM dithiothreitol) then resuspended at 6mg/ml. For
DNA binding to SA-PMPs, 150mg of SA-PMPs were
mixed with 3.6pmol biotinylated 118-bp template and
incubated at 32 C for 5min. The buffer was removed
from the template-linked SA-PMPs followed immediately
by addition of 8ml of transcription reaction mix contain-
ing 360nM mtTFA, 360nM mtTFB2, 600mM ATP,
150mM GTP, 100mM UTP, 60mM CTP and 0.33mM
[a-
32P] UTP (3000Ci/mmol) in POLRMT oligonucleotide
transcription buffer. Samples were incubated at 32 C for
2min to allow transcription factor binding then POLRMT
was added at 360nM to initiate transcription in a total
reaction volume of 10ml. After 2min, 60ng/ml heparin was
added to prevent further initiation and incubation was
continued at 32 C for 1, 5 or 15min when the SA-PMPs
were washed two times with 100ml3 2  C POLRMT tran-
scription buffer. Following buffer aspiration from the
SA-PMPs, POLRMT complexes were denatured by
heating at 80 C in 80% formamide/50mM EDTA
loading dye. Transcripts associated in stable complexes
on the SA-PMPs-linked templates were resolved by
20% polyacrylamide gel electrophoresis in TBE and
detected by phosphorimager analysis as above.
To conﬁrm that isolation of the arrested transcripts
was dependent upon biotinylated template linkage to
the SA-PMPs, identical transcription reactions were per-
formed with 3.6pmol of non-biotinylated, 118-bp
template followed by buffer washes and gel resolution as
above. As an additional control for the presence of
POLRMT with the arrested transcripts after the
SA-PMP washing step, reactions identical to those con-
taining the biotinylated 118-bp substrate, but without
[a-
32P] UTP, were performed and followed by SA-PMP
isolation and resolution of the template-associated
proteins by 4–20% SDS-PAGE in Tris–HEPES (Pierce,
Thermo Scientiﬁc, Rockford, IL, USA). Samples of the
puriﬁed mitochondrial proteins and a molecular weight
marker were resolved alongside the transcription
Nucleic Acids Research, 2010,Vol.38, No. 21 7549reaction samples, then proteins were detected in the gel by
silver staining.
RESULTS
M1dG and PdG adducts block POLRMT transcription
from LSP
We have employed an experimental design used previously
for assessing DNA damage arrest by T7RNAP and
RNAP II to analyze the behavior of POLRMT at a
site-speciﬁc M1dG adduct in the identical sequence
context following initiation at either LSP or HSP1
(30,44). Beginning with an analysis of transcripts
produced by POLRMT following LSP initiation, we
have compared transcript arrest by the adduct and its
PdG analog in each template as well as the extent of
arrest after initiation at the two promoters. Transcripts
from the LSP Xts and Xnts DNA transcription templates
were
32P labeled by radionucleotide incorporation along
an 18-base sequence cassette downstream of the transcrip-
tion start site for POLRMT (Figure 2). POLRMT was
stalled at the end of the labeling cassette on each DNA
molecule by exclusion of CTP. Following heparin
addition, all four ribonucleotides were provided for tran-
script elongation, which minimized further incorporation
of
32P due to the presence of the excess cold NTP (see
Supplementary Figure S1). By this method, the transcripts
produced during POLRMT elongation were the result of a
single promoter-initiated, transcription event on each
active DNA template molecule. Full-length, run-off tran-
scripts (RO) and transcripts resulting from arrest at the
adduct position (X) were identiﬁed by comparison with
32P-labeled, single-stranded DNA markers (Figure 3).
The percentage of POLRMT transcriptional arrest by
the adducts was determined by dividing the intensity of
the signal corresponding to adduct arrested transcripts by
the sum of the intensities of the arrested and run-off tran-
scripts in each sample lane on the gels.
M1dG present in the transcribed strand of the LSP
template arrested  70% of transcripts when paired with
C and >90% when paired with T (Figure 3A and C). The
PdG analog of M1dG blocked around 95% of POLRMT
elongation complexes regardless of base pairing, and
neither adduct in the nontranscribed strand affected
POLRMT transcription (Figure 3B). These results were
consistent with the ﬁndings from T7RNAP and RNAP
II experiments showing that the exocyclic M1dG is a
stronger block to elongation than the acyclic N
2-OPdG;
however, POLRMT arrest by the adducts was more sub-
stantial than that observed with the other polymerases
(30). The mitochondrial polymerase was more sensitive
to M1dG than the nuclear RNAP II (90% versus 70%
arrest, respectively), and POLRMT was impeded to a
much greater extent than the structurally similar T7
enzyme by both N
2-OPdG and M1dG, suggesting that
unique amino acid sequences in POLRMT or the associ-
ation of transcription factors with POLRMT may impart
functional differences to the POLRMT elongation
complex (1). As POLRMT is capable of transcript elong-
ation past the M1dG adduct, particularly its acyclic form
N
2-OPdG, a timecourse was performed to ascertain how
readily this bypass occurs.
POLRMT is capable of efﬁcient M1dG bypass
To determine the efﬁciency of POLRMT elongation past
M1dG and the relationship between POLRMT bypass and
M1dG structure, transcripts generated from the LSP Xts
templates were sampled at times up to 30min following
the restart of POLRMT elongation from the end of the
labeling cassette (Figure 4). On templates containing
M1dG opposite C, the appearance of POLRMT run-off
transcripts coincided with transcripts from arrest at the
adduct, indicating that N
2-OPdG caused a transient
block to POLRMT translocation (Figure 4A). On all tem-
plates, the total amount of transcription (arrested plus
run-off transcripts) reached a maximum within 1min,
and the proportion of run-off transcripts increased by
Figure 3. POLRMT arrest at M1dG and PdG in LSP templates. The
32P-labeled transcripts from 30min of elongation by POLRMT on LSP
Xts (A) and LSP Xnts (B) DNA templates containing dG (G), M1dG
(M) or PdG (P) paired with C (LSP Xts X:C and LSP Xtns X:C)o rT
(LSP Xts X:T) are shown. Adduct-arrested transcripts are indicated
with X and run-off transcripts with RO. Numbers in the center
indicate DNA marker lengths in lanes L100 and L10.( C) A graph
presenting the averages of the percent of transcripts arrested at
M1dG and PdG opposite C (white bars) or T (black bars) in at least
four independent experiments.
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total transcription did not increase over time, all
POLRMT complexes stalled at the labeling cassette ap-
parently restarted transcription simultaneously upon the
addition of NTPs, and the majority of POLRMT
complexes arrested at N
2-OPdG may be unstable. This
was supposed as the proportion of run-off transcripts
did not signiﬁcantly increase after the ﬁrst minute.
Similar elongation kinetics were observed for bypass of
M1dG:T (Figure 4B). As predicted from the 30-min elong-
ation reactions above, the exocyclic M1dG was a stronger
block than N
2-OPdG to transcription in the initial seconds
and arrest at the adduct was sustained over time.
Regardless of base pairing, PdG immediately halted
nearly all POLRMT transcription (Figure 4A, PdG:C;
PdG:T not shown), indicating that the chemical
dynamics of the exocyclic ring has a signiﬁcant inﬂuence
on POLRMT templating and translocation. It is possible
that POLRMT complexes that correctly insert cytosine
opposite N
2-OPdG or M1dG readily extend their tran-
scripts, while complexes that are incapable of insertion
or that incorporate another base quickly become
unstable and abort transcription. Indeed, if the exocyclic
ring is incapable of opening, as with the PdG adduct, base
insertion by POLRMT is apparently prevented.
PdG-arrested POLRMT transcription complexes are
stable
The arrested transcripts detected in the experiments above
may be released during detergent denaturation of stable
POLRMT complexes stalled at the adducts or may result
from the dissociation of unstable transcription complexes
soon after POLRMT encounters an adduct. As PdG
induced the strongest POLRMT transcription arrest,
biotinylated, oligonucleotide templates containing the
LSP and PdG adduct were utilized for in vitro analysis
of arrested POLRMT complex stability (Figure 5).
Transcripts corresponding to POLRMT arrest at the
PdG adduct were observed up to 15min after heparin
addition and appear to reﬂect insertion up to and
possibly opposite the adduct (Figure 5C). The arrested
transcripts were absent in reactions containing a
biotinylated, undamaged 118-bp template and isolation
of the transcripts depended upon biotin linkage of the
damaged template to the SA-PMPs (data not shown).
The DNA marker (at 40nt) served only to approximate
the migration of the arrested transcripts, expected to be 35
or 36nt, because mobility discrepancies between short
DNA and RNA are known to occur. The transcripts
produced by POLRMT complexes were formed prior to
heparin addition and were released only when denatured
with formamide after washes with copious amounts of
buffer, indicating that they are a part of stable transcrip-
tion complexes on the templates. Further evidence for
arrested elongation complex stability was revealed when
POLRMT was found in association with the PdG-
containing biotinylated template following SA-PMP iso-
lation from 1-min transcription reactions (data not
shown).
While the time-course studies were conducted with an
equimolar excess of NTPs to favor adduct bypass, the
reactions to assess stability contained NTPs at a molar
ratio of 6 ATP:1.5 GTP:1 UTP:0.6 CTP, which was
based on a report of mitochondrial NTP levels in HeLa
cells and intended to emulate biological conditions (52).
The shorter oligonucleotide templates in this analysis also
allowed for the detection of RNA products that may have
resulted from templating by the adduct (Figure 5C, X) and
suggest that further studies of insertion kinetics by
POLRMT at M1dG and PdG are warranted.
Figure 4. POLRMT transcriptional bypass of M1dG or PdG following initiation at LSP. POLRMT damage-arrested (X) and full-length (RO)
transcripts from LSP Xts templates containing dG, M1dG, and PdG paired with C [dG:C, M1dG:C, and PdG:C,( A)] or with T [M1dG:T,( B)] are
shown at times following the NTP stimulation of POLRMT elongation. Numbers at the side of the gels indicate DNA marker lengths in the adjacent
lanes. The gels shown are one of at least three independent experiments for each template.
Nucleic Acids Research, 2010,Vol.38, No. 21 7551POLRMT elongation complexes initiated from HSP1 are
less sensitive to M1dG and PdG
POLRMT molecules initiating transcription at LSP and
HSP1 in mtDNA are responsive to different signals in the
mitochondrial chromosome controlling the length of
RNA transcripts (31,36–39). LSP directs transcription of
both a polycistronic transcript, nearly the length of the
chromosome, and a short RNA primer for mtDNA H
strand replication. HSP1 initiates POLRMT transcription
to produce an rRNA transcript that terminates at a
sequence within the tRNA
Leu gene (38,39). Previous
studies have characterized POLRMT activity at both pro-
moters in the presence of mtTFA and mtTFB2 (33,44).
Here, we have compared the response of POLRMT to
M1dG and PdG following POLRMT initiation at HSP1
and LSP in our in vitro templates (Figure 2).
An analysis of the transcripts from POLRMT elong-
ation on the HSP Xts and Xnts templates are shown in
Figure 6. As expected, POLRMT translocation was
impeded to a greater extent by M1dG, which arrested
nearly 80% of HSP1-initiated transcripts, while the
acyclic N
2-OPdG arrested  60% of POLRMT transcripts
(lanes M, panel A and panel C). PdG blocked nearly all
transcript elongation (lanes P, panel A) regardless of base
pairing, and no arrested transcripts were observed when
the adducts were in the nontranscribed strand (panel B).
Surprisingly, the amount of transcripts arrested by N
2-
OPdG and M1dG was 10% lower from HSP templates
than from LSP templates (Table 1), and POLRMT inter-
action with the adducts when opposite T resulted in tran-
scripts that appear to arrest immediately and to continue
several bases past the adducts. It is unclear whether
POLRMT response to the T-paired adducts relates to
properties imparted to the polymerase by HSP1 at initi-
ation or to long-range DNA structural effects on HSP1
stemming from a distortion at the mispaired adducts that
alter initiation site selection by POLRMT. Two tran-
scripts of  315 and 340 bases in length were noted in
the lanes for samples with the undamaged and M1dG tem-
plates (Figure 6A, lanes G and M). These products likely
resulted from stalling of POLRMT at pause sites in the
sequence downstream of the adduct position and were not
as apparent for POLRMT transcription of the identical
sequences in the LSP templates (Figure 3). The distinctive
POLRMT pausing after HSP1 and the differences in
response to T-paired adducts in the HSP and LSP tem-
plates may relate to recently reported differences in
POLRMT initiation that could affect POLRMT inter-
action with the template strand during elongation (44).
Taken together, these ﬁndings indicate that POLRMT
complexes on both strands of the mitochondrial chromo-
some will respond to M1dG in a structure-dependent
manner but that POLRMT transcribing the rRNA genes
from HSP1 on the G-rich H strand may more readily
bypass both forms of the endogenous adduct.
POLRMT elongation complexes initiated from HSP1 also
efﬁciently bypass N
2-OPdG
To assess whether the kinetics for adduct bypass are
promoter-dependent, POLRMT transcripts initiated at
HSP1 were isolated at times up to 30min following NTP
stimulation of elongation (Figure 7). As observed with the
LSP templates, all POLRMT molecules appeared to
resume transcription concurrently upon NTP addition
and to complete elongation within the initial minute.
While PdG immediately blocked >95% of POLRMT
Time (min) 15 1 5 L 10
40
X
C
X
+1 +36 mtTFA site A
SA-PMPs
DNA
5 min
mtTFA
mtTFB2
NTPs
2 min
POLRMT
2 min
heparin
Wash after
1, 5, or 15 min
B
Figure 5. POLRMT complex stability when arrested by PdG. (A) A schematic of the 118-bp POLRMT template containing LSP and a dG or PdG
(position X) 36 bases downstream of LSP is shown. The mtTFA binding site is boxed and shaded, and the start site is indicated by the arrow at+1.
(B) The schematic for the reactions to assesses POLRMT complex stability. (C) Transcripts isolated from stable POLRMT complexes arrested at
PdG (X) are shown at times following heparin addition. A 40-nt DNA marker is shown in lane L10. The gel shown is one of three independent
experiments.
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2-OPdG initially arrested around
60% of the transcripts, with run-off transcripts increasing
slightly over the ﬁrst 5min. While POLRMT was less sen-
sitive to N
2-OPdG following HSP1 initiation, the rate at
which bypass occurred did not differ signiﬁcantly from
that observed with LSP template. This indicates that
neither the stability of POLRMT complexes arrested at
these adducts nor the kinetics for POLRMT bypass of
N
2-OPdG is dependent on the promoter directing tran-
scription. The ﬁndings from this in vitro system indicate
that M1dG in mtDNA may cause stable arrest of
POLRMT complexes thereby interfering with elongation
from subsequent initiation events, and in essence,
inactivating a polycistronic region of the mitochondrial
chromosome.
DISCUSSION
In the nucleus, RNAP II serves as a sensitive DNA
damage recognition factor for NER to increase the efﬁ-
ciency of repair in the transcribed relative to the
nontranscribed strand of active genes (53). M1dG is a
target of NER and inhibits transcription by mammalian
RNAP II and the bacteriophage T7RNAP (16,30).
RNAP II arrest by M1dG may facilitate NER recognition
and removal the adduct from nuclear DNA, but
mitochondria have no known mechanism comparable to
NER (16–18). Indeed, our current knowledge of mtDNA
repair suggests that the arrest of POLRMT would have
only deleterious consequences for mitochondrial function
and cellular health. Since M1dG occurs in mitochondria at
a 2-fold higher base frequency than in nuclear DNA, the
mitochondrial chromosomes are highly susceptible to
genetic instability due to the presence of this endogenous
form of DNA damage (11).
Our study has provided insight into the ramiﬁcations of
persistent M1dG for mtDNA gene expression through the
use of a POLRMT in vitro transcription system including
templates with site-speciﬁc M1dG and PdG adducts and
the mitochondrial transcription factors, mtTFA and
mtTFB2. The DNA template sequence context of the
adducts was identical to that in previous work
characterizing the effects of M1dG and PdG on RNAP
II and T7RNAP transcript elongation; therefore, the
behavior of the three polymerases at the adducts could
be compared for evident differences in their biochemical
function (30).
As observed with T7RNAP and RNAP II, POLRMT
arrest by M1dG was dependent upon the structure of the
adduct such that the polymerase more readily bypassed
the ring-open N
2-OPdG (formed when M1dG is opposite
C) than the exocyclic M1dG (when M1dG is opposite T)
(Table 1). PdG, the closed-ring analog of M1dG, halted
nearly all POLRMT elongation, suggesting that chemical
dynamics of M1dG may allow the active site of POLRMT
to accommodate templating and insertion of a
ribonucleotide for bypass of the endogenous adduct (54).
Nuclear magnetic resonance (NMR) studies have shown
that the oxopropenyl group of N
2-OPdG lies within the
DNA minor groove and causes little distortion at the base
pair (19), while PdG, the planar analog of the M1dG,
participates in Hoogsteen pairing and rotates to a syn
conformation at the glycosylic bond placing the exocyclic
ring in the major groove (55). M1dG is predicted to cause
base pair distortions similar to those observed in DNA
containing PdG; however, the chemistry of the M1dG
ring appears to determine the behavior of RNA polymer-
ases attempting to ‘read’ the adduct during transcription.
Figure 6. POLRMT arrest at M1dG and PdG in HSP templates. The
32P-labeled transcripts from (A) HSP Xts templates (HSP Xts X:C and
HSP Xts X:T)o r( B) HSP Xnts X:C templates containing dG (G),
M1dG (M) or PdG (P). Adduct-arrested (X) and run-off (RO) tran-
scripts are indicated. Numbers at the sides indicate DNA marker
lengths in lanes L100 and L10.( C) A graph presenting the averages
of the percent of transcripts arrested at M1dG and PdG opposite C
(white bars) or T (black bars) for at least four independent experiments.
Table 1. POLRMT, RNAP II and T7RNAP transcriptional arrest
induced by M1dG and PdG (30)
X:(C/T)
a POLRMT
b (%) RNAP II (%) T7RNAP (%)
N
2-OPdG LSP 68±5.4 60 27
(M1dG:C) HSP1 59.9±3.6
M1dG LSP 92.1±6.8 70 36
(M1dG:T) HSP1 82.7±3.3
PdG LSP & HSP1  95 100 68
aX=M 1dG shown opposite either C or T; X=PdG results were
similar regardless of base pairing.
bPOLRMT transcriptional arrest according to the initiating promoter,
LSP or HSP1.
Nucleic Acids Research, 2010,Vol.38, No. 21 7553The observed differences in the arrest of T7RNAP, RNAP
II and POLRMT by M1dG within an identical sequence
context suggest that the polymerases have unique active
site interactions with the transcribed strand and with the
adduct itself during elongation.
The initiation and elongation mechanisms of T7RNAP
and RNAP II have been characterized through biochem-
ical and structural studies, but information about
POLRMT is limited. Based on its sequence homology to
T7RNAP, POLRMT has been presumed to operate much
like the single-subunit bacteriophage enzyme (1,31).
However, our results suggest that POLRMT elongation
complexes have properties that cannot be predicted from
structural alignments with the T7 enzyme. POLRMT
arrest at N
2-OPdG and M1dG was 2-fold greater than
that observed for T7RNAP, indicating that
nonhomologous active site or amino terminal sequence
in POLRMT may affect function (Table 1). The amino
terminal domain, which is not found in T7RNAP, may
also help establish promoter-speciﬁc conformations of
the POLRMT transcription complex through associations
with transcription factors and the promoter. POLRMT
displayed greater sensitivity to M1dG and N
2-OPdG
after initiation at LSP than at HSP1 (promoter differences
for N
2-OPdG, P=0.002 and for M1dG, P=0.018, in a
two-tailed, unpaired t-test), and transcripts from possible
pause sites were more apparent from transcription of the
HSP templates (Figure 6). This ﬁnding indicates that
promoter sequence may play a signiﬁcant role in
determining POLRMT interaction with the template
during transcript elongation.
While the extent of POLRMT arrest at M1dG and
N
2-OPdG was promoter dependent, the ability of the
enzyme to transcribe past the adducts was not. On both
LSP and HSP1 templates, POLRMT transcription
reached maximal levels (assessed as the sum of all tran-
scripts) within the ﬁrst minute of elongation (Figures 4
and 7). The majority of N
2-OPdG and M1dG bypass
occurred during the ﬁrst minute, with only a  5%
increase in the proportion of run-off transcripts thereafter.
This indicates that POLRMT base insertion opposite both
ring structures of the adduct occurs readily in the ﬁrst
seconds of elongation, but POLRMT extension of tran-
scripts may depend on the base inserted by enzyme. If
arrested POLRMT complexes remained stable over the
time course, a gradual increase in the run-off transcripts
would have been expected due to delayed nucleotide in-
sertion opposite the adduct and continued elongation by
POLRMT. However, the arrested transcripts did not
appear to lengthen past the adducts after the initial
5min, suggesting that POLRMT dissociated from the
template and released the truncated RNAs. These
ﬁndings indicate that N
2-OPdG and M1dG stall
POLRMT and induce elongation complex instability if
nucleotide insertion does not occur within a short time
frame after POLRMT encounters the damage. Further
studies are necessary to determine properties of
POLRMT base insertion at M1dG and whether the result-
ing transcripts are extended with different efﬁciencies by
the enzyme.
Under conditions that approximate the NTP ratios
present in mitochondria (52), POLRMT elongation
complexes arrested at PdG remain stable for several
minutes in vitro and possibly contain transcripts that
include a nucleotide insertion opposite the adduct
(Figure 5C). A detailed investigation of POLRMT inser-
tion kinetics opposite M1dG will be necessary to assess the
potential impact of the transcriptional arrest on mtDNA
Figure 7. POLRMT transcriptional bypass of M1dG or PdG following initiation at HSP1. POLRMT damage-arrested (X) and full-length (RO)
transcripts from HSP Xts templates containing dG, M1dG and PdG paired with C (dG:C, M1dG:C or PdG:C) are shown at times following NTP
stimulation of POLRMT elongation. Numbers at the left of each gel indicate DNA marker lengths in the adjacent lanes. The gels shown are one of
three independent experiments.
7554 Nucleic Acids Research, 2010,Vol.38, No. 21gene expression. Mitochondria may contain factors
resembling nuclear elongation factor SII that could inter-
vene to rescue stable complexes; however, such a factor or
proteins constituting a repair mechanism to remove the
guanine adducts have yet to be identiﬁed. Whether
POLRMT complexes continue past M1dG or become
unstable after damage arrest, essential transcripts will
not be produced in a timely fashion resulting in a deﬁ-
ciency of mitochondrial RNAs and proteins, an imbalance
in the transcription of the mtDNA strands, and perhaps a
failure of mtDNA replication and mitochondrial
biogenesis.
Only a few human mitochondrial proteins involved in
POLRMT transcript initiation and elongation have been
identiﬁed (31,56). A recent study identiﬁed several
proteins associating with the yeast polymerase, Rpo41p,
that may have human orthologs (57). The human
POLRMT contains a unique pentatricopeptide repeat
sequence in its amino terminal domain that could
mediate speciﬁc interactions with the RNA transcript or
with proteins that couple transcription and translation
(56,58). Yet to be discovered factors in the organelle
also could enhance POLRMT elongation complex stabil-
ity, enable transcriptional bypass of DNA damage or
facilitate mtDNA damage repair. While T7RNAP lacks
associated proteins, RNAP II carries several factors
during elongation and recruits additional proteins when
arrested at pause sites or DNA damage (59,60). The
previous study of M1dG arrest of RNAP II revealed
that RNAP II complexes remain stable at PdG and are
responsive to the elongation factor SII (59,61). While SII
stimulates an RNAP II nuclease activity, an activity not
associated with POLRMT, it is possible that a mitochon-
drial factor may associate with arrested POLRMT elong-
ation complexes to prevent dissociation or to promote
backward translocation of POLRMT from a damaged
base to permit mtDNA repair.
As no NER-like mechanism for M1dG repair has been
identiﬁed in mitochondria, the ﬁndings presented here
suggest that this endogenous form of DNA damage may
signiﬁcantly impair mitochondrial gene expression by
arrest of POLRMT or by induction of transcriptional mu-
tagenesis. Studies are underway to characterize M1dG
effects on POLRMT nucleotide insertion kinetics and
ﬁdelity to better understand the biological impact of our
ﬁndings. Certainly, this work has led us to consider
whether the inability of mitochondria to repair M1dG
and M1dG effects on mtDNA transcription contribute
to the decline in cellular energy production observed in
aging and diseased tissues.
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